11/05/2019 – Webconference presentation on masitinib + isoquercetin in COVID-19 Category: 2020By Alexis BERNARD11 May 2019Tags: 2019 Partager cet article Share on LinkedInShare on LinkedIn Share on XShare on X Share on FacebookShare on Facebook Share on WhatsAppShare on WhatsApp Pin itShare on Pinterest Author: Alexis BERNARD Post navigationPreviousPrevious post:Annual financial results as of 31 December, 2018NextNext post:Lifting of the ANSM clinical holdRelated PostsBoursorama interview of Alain Moussy, CEO of AB Science23 December 2020Capital raise for a total amount of 15 million euros21 December 2020Results from phase 2B/3 study evaluating masitinib in Alzheimer’s disease18 December 2020Masitinib in Alzheimer’s Disease Webcast Presentation17 December 2020Results of the Extraordinary General Shareholders’ Meeting of December 16, 202017 December 2020Corrective press release regarding adverse events information from study AB0900417 December 2020
